Rummel MJ - Search Results

1

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.

Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Rummel MJ, et al. Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20. Lancet. 2013. PMID: 23433739 Clinical Trial.

2

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse.

Rummel MJ, Chow KU, Jäger E, Hossfeld DK, Bergmann L, Peters HD, Hansmann ML, Meyer A, Hoelzer D, Mitrou PS. Rummel MJ, et al. Ann Oncol. 1999 Jan;10(1):115-7. doi: 10.1023/a:1008325212484. Ann Oncol. 1999. PMID: 10076731 Free article. Clinical Trial.

3

Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II study.

Rummel MJ, Käfer G, Pfreundschuh M, Jäger E, Reinhardt U, Mitrou PS, Hoelzer D, Bergmann L. Rummel MJ, et al. Ann Oncol. 1999 Feb;10(2):183-8. doi: 10.1023/a:1008312432416. Ann Oncol. 1999. PMID: 10093687 Free article. Clinical Trial.

4

Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas.

Rummel MJ, Chow KU, Jäger E, Leimer L, Hossfeld DK, Bergmann L, Peters HD, Hansmann ML, Meyer A, Hoelzer D, Mitrou PS. Rummel MJ, et al. Leuk Lymphoma. 1999 Sep;35(1-2):129-38. doi: 10.3109/10428199909145712. Leuk Lymphoma. 1999. PMID: 10512170 Clinical Trial.

5

Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine.

Weidmann E, Boehrer S, Chow KU, Engels K, Harder L, Hinz T, Janssen O, Kriener S, Rummel MJ, Siebert R, Kabelitz D, Hansmann ML, Hoelzer D, Mitrou PS; Study Group Peripheral T- and NK-Cell Neoplasias. Weidmann E, et al. Among authors: rummel mj. Onkologie. 2001 Apr;24(2):162-4. doi: 10.1159/000050305. Onkologie. 2001. PMID: 11441297

6

Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.

Chow KU, Sommerlad WD, Boehrer S, Schneider B, Seipelt G, Rummel MJ, Hoelzer D, Mitrou PS, Weidmann E. Chow KU, et al. Among authors: rummel mj. Haematologica. 2002 Jan;87(1):33-43. Haematologica. 2002. PMID: 11801463

7

Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells.

Chow KU, Boehrer S, Bojunga J, Stieler M, Rummel MJ, Fauth F, Schneider B, Martin H, Hoelzer D, Weidmann E, Mitrou PS. Chow KU, et al. Among authors: rummel mj. Leuk Lymphoma. 2002 Feb;43(2):377-84. doi: 10.1080/10428190290006198. Leuk Lymphoma. 2002. PMID: 11999573

8

In vitro studies with bendamustine: enhanced activity in combination with rituximab.

Rummel MJ, Chow KU, Hoelzer D, Mitrou PS, Weidmann E. Rummel MJ, et al. Semin Oncol. 2002 Aug;29(4 Suppl 13):12-4. doi: 10.1053/sonc.2002.34873. Semin Oncol. 2002. PMID: 12170426

9

Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.

Rummel MJ, Mitrou PS, Hoelzer D. Rummel MJ, et al. Semin Oncol. 2002 Aug;29(4 Suppl 13):27-32. doi: 10.1053/sonc.2002.34877. Semin Oncol. 2002. PMID: 12170430 Review.

10

Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma.

Rummel MJ, Chow KU, Karakas T, Jäger E, Mezger J, von Grünhagen U, Schalk KP, Burkhard O, Hansmann ML, Ritzel H, Bergmann L, Hoelzer D, Mitrou PS. Rummel MJ, et al. Eur J Cancer. 2002 Sep;38(13):1739-46. doi: 10.1016/s0959-8049(02)00143-0. Eur J Cancer. 2002. PMID: 12175690 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page